Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm, Residual × asparaginase erwinia chrysanthemi recombinant × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Leukemia 5 Leukemia, Myeloid, Acute 3 Recurrence 2 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoproliferative Disorders 1 Lymphoma 1 Leukemia, Biphenotypic, Acute 1 Immunoproliferative Disorders 1 Hypersensitivity 1 Down Syndrome 1

Interventions

Rituximab 4 blinatumomab 3 Whole-Body Irradiation 2 Lenalidomide 2 Cyclophosphamide 2 Clofarabine 2 treosulfan 1 thymoglobulin 1 sabatolimab 1 peginterferon alfa-2a 1 obinutuzumab 1 midostaurin 1 ixazomib 1 fludarabine phosphate 1 fludarabine 1 eribulin 1 daratumumab 1 acalabrutinib 1 Trastuzumab 1 Tacrolimus 1 Sodium Chloride 1 Peripheral Blood Stem Cell Transplantation 1 Pentostatin 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Magnetic Resonance Imaging 1 Imatinib Mesylate 1 Histamine Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡